Personal tools

MCL coexpression mm9:233: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0.360069300129636,0.885764903252032,0.940095963022424,0.324525627689665,0.254722434166292,0.383936593057231,0.252071962936197,0,0,0,0.108474404877635,0.0558041721483835,0,0,0.0959499323579933,0.100783889465809,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.545454304287177,0.408692801612187,0.311127917657318,0.930038297778725,0.484176860335644,0.534984022513845,0,0,0,0,0,0,0,0,0,0.200034908790818,0.364439294176354,0.37002711790928,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0753494505378687,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100004302423367,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.13336176105449,0.167389851124624,0.0983461768813133,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0236264046620649,0.0543101607623745,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0331417600494206,0,0,0,0,0,0,0,0,0,0,0,0,0.0681778550615498,0.211728719351586,0.105986777695408,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0115846497345053,0,0.0208870423994129,0.0200223090406663,0.037610243787174,0.0588625755917643,0.0764305931706906,0.0486365415729897,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0.360069300129636,0.885764903252032,0.940095963022424,0.324525627689665,0.254722434166292,0.383936593057231,0.252071962936197,0,0,0,0.108474404877635,0.0558041721483835,0,0,0.0959499323579933,0.100783889465809,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.545454304287177,0.408692801612187,0.311127917657318,0.930038297778725,0.484176860335644,0.534984022513845,0,0,0,0,0,0,0,0,0,0.200034908790818,0.364439294176354,0.37002711790928,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0753494505378687,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100004302423367,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.13336176105449,0.167389851124624,0.0983461768813133,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0236264046620649,0.0543101607623745,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0331417600494206,0,0,0,0,0,0,0,0,0,0,0,0,0.0681778550615498,0.211728719351586,0.105986777695408,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0115846497345053,0,0.0208870423994129,0.0200223090406663,0.037610243787174,0.0588625755917643,0.0764305931706906,0.0486365415729897,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|gostat_on_MCL_coexpression=GO:0043154;negative regulation of caspase activity;0.0249801416016453;12633!GO:0030693;caspase activity;0.0416153195043072;12633!GO:0003697;single-stranded DNA binding;0.0416153195043072;109019!GO:0043281;regulation of caspase activity;0.0483632233160235;12633!
|gostat_on_MCL_coexpression=GO:0043154;negative regulation of caspase activity;0.0249801416016453;12633!GO:0030693;caspase activity;0.0416153195043072;12633!GO:0003697;single-stranded DNA binding;0.0416153195043072;109019!GO:0043281;regulation of caspase activity;0.0483632233160235;12633!
|ontology_enrichment_celltype=CL:0000838!6.29e-29!12;CL:0000084!9.91e-27!11;CL:0000827!9.91e-27!11;CL:0000542!1.73e-26!13;CL:0000051!1.73e-26!13;CL:0000988!9.05e-24!32;CL:0002032!9.05e-24!32;CL:0000037!9.05e-24!32;CL:0000566!9.05e-24!32;CL:0000837!9.05e-24!32;CL:0000791!1.09e-22!9;CL:0000789!1.09e-22!9;CL:0002420!1.09e-22!9;CL:0002419!1.09e-22!9;CL:0000790!1.09e-22!9;CL:0002242!5.34e-21!16;CL:0000624!2.54e-20!8;CL:0000738!1.34e-19!17;CL:0002087!1.34e-19!17;CL:0002031!5.48e-17!25;CL:0002320!6.14e-17!46;CL:0000134!6.14e-17!46;CL:0000893!1.09e-15!6;CL:0002489!1.09e-15!6;CL:0000898!1.09e-15!6;CL:0000809!1.09e-15!6;CL:0000810!1.09e-15!6;CL:0000895!1.09e-15!6;CL:0000808!1.09e-15!6;CL:0000894!1.09e-15!6;CL:0000806!1.09e-15!6;CL:0000807!1.09e-15!6;CL:0000805!1.09e-15!6;CL:0002425!1.09e-15!6;CL:0002436!1.09e-15!6;CL:0002427!1.09e-15!6;CL:0002428!1.09e-15!6;CL:0002429!1.09e-15!6;CL:0002433!1.09e-15!6;CL:0002431!1.09e-15!6;CL:0002432!1.09e-15!6;CL:0000219!1.00e-13!54;CL:0000034!1.60e-11!97;CL:0000723!2.84e-09!91;CL:0000048!2.84e-09!91
|ontology_enrichment_disease=DOID:0060100!1.02e-08!3;DOID:4045!1.02e-08!3
|ontology_enrichment_uberon=UBERON:0002384!6.14e-17!46;UBERON:0002370!1.03e-14!23;UBERON:0000974!1.03e-14!23;UBERON:0004807!1.03e-14!23;UBERON:0005058!1.03e-14!23;UBERON:0003351!1.03e-14!23;UBERON:0009113!1.03e-14!23;UBERON:0003295!1.03e-14!23;UBERON:0009722!1.03e-14!23;UBERON:0005562!1.03e-14!23;UBERON:0007690!1.03e-14!23;UBERON:0006562!5.54e-14!24;UBERON:0003408!5.54e-14!24;UBERON:0001557!5.54e-14!24;UBERON:0001042!5.54e-14!24;UBERON:0008814!5.54e-14!24;UBERON:0009145!5.54e-14!24;UBERON:0000072!4.09e-12!27;UBERON:0002193!1.06e-11!48;UBERON:0002405!1.06e-11!48;UBERON:0002390!3.50e-11!45;UBERON:0003061!3.50e-11!45;UBERON:0004177!4.38e-11!29;UBERON:0005057!4.38e-11!29;UBERON:0000077!3.25e-10!35;UBERON:0000063!1.04e-08!35;UBERON:0007811!2.15e-08!36;UBERON:0000065!4.82e-07!41;UBERON:0001004!8.19e-07!42;UBERON:0000490!8.87e-07!66
}}
}}

Revision as of 18:17, 11 October 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:67000447..67000459,-p@chr10:67000447..67000459
-
Mm9::chr10:79622451..79622464,-p@chr10:79622451..79622464
-
Mm9::chr11:3005053..3005065,+p@chr11:3005053..3005065
+
Mm9::chr12:56567352..56567359,-p@chr12:56567352..56567359
-
Mm9::chr14:75579610..75579615,+p@chr14:75579610..75579615
+
Mm9::chr15:101096964..101096995,-p@chr15:101096964..101096995
-
Mm9::chr15:72979452..72979460,+p@chr15:72979452..72979460
+
Mm9::chr15:78603087..78603092,+p@chr15:78603087..78603092
+
Mm9::chr16:90283464..90283475,+p@chr16:90283464..90283475
+
Mm9::chr17:21587220..21587237,-p@chr17:21587220..21587237
-
Mm9::chr17:29631445..29631468,+p@chr17:29631445..29631468
+
Mm9::chr17:8068222..8068232,+p@chr17:8068222..8068232
+
Mm9::chr17:8068242..8068258,+p@chr17:8068242..8068258
+
Mm9::chr1:140033030..140033043,-p@chr1:140033030..140033043
-
Mm9::chr1:140072205..140072214,+p@chr1:140072205..140072214
+
Mm9::chr1:164501625..164501636,-p@chr1:164501625..164501636
-
Mm9::chr1:51535234..51535250,-p1@Obfc2a
Mm9::chr1:58770222..58770225,+p15@Cflar
Mm9::chr1:92953069..92953085,-p@chr1:92953069..92953085
-
Mm9::chr1:92959315..92959328,+p@chr1:92959315..92959328
+
Mm9::chr2:73323384..73323388,+p@chr2:73323384..73323388
+
Mm9::chr3:40550589..40550592,+p@chr3:40550589..40550592
+
Mm9::chr4:116793059..116793074,-p@chr4:116793059..116793074
-
Mm9::chr5:115939839..115939849,-p@chr5:115939839..115939849
-
Mm9::chr5:115939964..115939990,-p@chr5:115939964..115939990
-
Mm9::chr5:38611621..38611635,-p2@Zbtb49
Mm9::chr6:129183076..129183130,+p@chr6:129183076..129183130
+
Mm9::chr6:129187104..129187117,-p@chr6:129187104..129187117
-
Mm9::chr6:129187277..129187288,+p@chr6:129187277..129187288
+
Mm9::chr6:129234454..129234459,-p@chr6:129234454..129234459
-
Mm9::chr7:108450534..108450596,-p1@Atg16l2
Mm9::chr7:31204698..31204711,+p@chr7:31204698..31204711
+
Mm9::chr7:97277849..97277866,-p@chr7:97277849..97277866
-
Mm9::chr8:23817098..23817104,+p@chr8:23817098..23817104
+
Mm9::chr9:44795249..44795263,-p@chr9:44795249..44795263
-
Mm9::chr9:44795268..44795283,-p@chr9:44795268..44795283
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0043154negative regulation of caspase activity0.0249801416016453
GO:0030693caspase activity0.0416153195043072
GO:0003697single-stranded DNA binding0.0416153195043072
GO:0043281regulation of caspase activity0.0483632233160235



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

Cell Type
Ontology termp-valuen
lymphoid lineage restricted progenitor cell6.29e-2912
T cell9.91e-2711
pro-T cell9.91e-2711
lymphocyte1.73e-2613
common lymphoid progenitor1.73e-2613
hematopoietic cell9.05e-2432
hematopoietic oligopotent progenitor cell9.05e-2432
hematopoietic stem cell9.05e-2432
angioblastic mesenchymal cell9.05e-2432
hematopoietic multipotent progenitor cell9.05e-2432
mature alpha-beta T cell1.09e-229
alpha-beta T cell1.09e-229
immature T cell1.09e-229
mature T cell1.09e-229
immature alpha-beta T cell1.09e-229
nucleate cell5.34e-2116
CD4-positive, alpha-beta T cell2.54e-208
leukocyte1.34e-1917
nongranular leukocyte1.34e-1917
hematopoietic lineage restricted progenitor cell5.48e-1725
connective tissue cell6.14e-1746
mesenchymal cell6.14e-1746
thymocyte1.09e-156
double negative thymocyte1.09e-156
naive T cell1.09e-156
double-positive, alpha-beta thymocyte1.09e-156
CD4-positive, alpha-beta thymocyte1.09e-156
naive thymus-derived CD4-positive, alpha-beta T cell1.09e-156
DN4 thymocyte1.09e-156
DN1 thymic pro-T cell1.09e-156
DN2 thymocyte1.09e-156
DN3 thymocyte1.09e-156
immature single positive thymocyte1.09e-156
early T lineage precursor1.09e-156
mature CD4 single-positive thymocyte1.09e-156
resting double-positive thymocyte1.09e-156
double-positive blast1.09e-156
CD69-positive double-positive thymocyte1.09e-156
CD69-positive, CD4-positive single-positive thymocyte1.09e-156
CD4-positive, CD8-intermediate double-positive thymocyte1.09e-156
CD24-positive, CD4 single-positive thymocyte1.09e-156
motile cell1.00e-1354
stem cell1.60e-1197
somatic stem cell2.84e-0991
multi fate stem cell2.84e-0991

Uber Anatomy
Ontology termp-valuen
connective tissue6.14e-1746
thymus1.03e-1423
neck1.03e-1423
respiratory system epithelium1.03e-1423
hemolymphoid system gland1.03e-1423
pharyngeal epithelium1.03e-1423
thymic region1.03e-1423
pharyngeal gland1.03e-1423
entire pharyngeal arch endoderm1.03e-1423
thymus primordium1.03e-1423
early pharyngeal endoderm1.03e-1423
pharynx5.54e-1424
gland of gut5.54e-1424
upper respiratory tract5.54e-1424
chordate pharynx5.54e-1424
pharyngeal arch system5.54e-1424
pharyngeal region of foregut5.54e-1424
segment of respiratory tract4.09e-1227
hemolymphoid system1.06e-1148
immune system1.06e-1148
hematopoietic system3.50e-1145
blood island3.50e-1145
hemopoietic organ4.38e-1129
immune organ4.38e-1129
mixed endoderm/mesoderm-derived structure3.25e-1035
organ segment1.04e-0835
craniocervical region2.15e-0836
respiratory tract4.82e-0741
respiratory system8.19e-0742
unilaminar epithelium8.87e-0766

Disease
Ontology termp-valuen
musculoskeletal system cancer1.02e-083
muscle cancer1.02e-083


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:233&oldid=2154544"